Abstract
Advances in genomics are enabling the early recognition of hereditary prostate cancer with important diagnostic and prognostic implications, helping with access to personalised targeted therapies and opportunities for early cancer detection and prevention.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
